{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:03Z","timestamp":1786119603275,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/01.aids.0000391022.95412.a6","type":"journal-article","created":{"date-parts":[[2010,11,13]],"date-time":"2010-11-13T04:19:14Z","timestamp":1289621954000},"page":"S49-S56","source":"Crossref","is-referenced-by-count":37,"title":["The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB\/HIV in Rio (THRio) Study"],"prefix":"10.1097","volume":"24","author":[{"given":"Betina","family":"Durovni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange C","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Saraceni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitoria","family":"Vellozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Israel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie S","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Efron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio G","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H","family":"Moulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E","family":"Chaisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E","family":"Golub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20210130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":"Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy","volume":"34","author":"Santoro-Lopes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R3-8-20210130","first-page":"1026","article-title":"HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult\/Adolescent Spectrum of HIV Disease Group","volume":"4","author":"Jones","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"R4-8-20210130","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1097\/00002030-200009080-00015","article-title":"Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection","volume":"14","author":"Girardi","year":"2000","journal-title":"AIDS"},{"key":"R5-8-20210130","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"R6-8-20210130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","article-title":"A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration","volume":"337","author":"Whalen","year":"1997","journal-title":"N Engl J Med"},{"key":"R7-8-20210130","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(97)06532-X","article-title":"Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection","volume":"351","author":"Halsey","year":"1998","journal-title":"Lancet"},{"key":"R8-8-20210130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0140-6736(93)91817-6","article-title":"Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection","volume":"342","author":"Pape","year":"1993","journal-title":"Lancet"},{"key":"R9-8-20210130","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","article-title":"Twice weekly tuberculosis preventive therapy in HIV infection in Zambia","volume":"12","author":"Mwinga","year":"1998","journal-title":"AIDS"},{"key":"R10-8-20210130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM199707313370505","article-title":"A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS","volume":"337","author":"Gordin","year":"1997","journal-title":"N Engl J Med"},{"key":"R12-8-20210130","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/00002030-200111090-00008","article-title":"Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil","volume":"15","author":"de Pinho","year":"2001","journal-title":"AIDS"},{"key":"R14-8-20210130","first-page":"769","article-title":"Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil","volume":"12","author":"Saraceni","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"R15-8-20210130","doi-asserted-by":"crossref","first-page":"e3132","DOI":"10.1371\/journal.pone.0003132","article-title":"AIDS-related tuberculosis in Rio de Janeiro, Brazil","volume":"3","author":"Pacheco","year":"2008","journal-title":"PLoS ONE"},{"key":"R19-8-20210130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/1740774507076937","article-title":"Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention","volume":"4","author":"Moulton","year":"2007","journal-title":"Clin Trials"},{"key":"R20-8-20210130","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil","volume":"21","author":"Golub","year":"2007","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201011005-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:37:43Z","timestamp":1786041463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201011005-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":14,"journal-issue":{"issue":"Suppl 5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000391022.95412.a6","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}